NEWS
05/27/2016 07:29 EDT | Updated 05/28/2017 01:12 EDT

Canadian class action claims Johnson's baby powder failed to warn of health risk

TORONTO — A Canadian class-action lawsuit has been filed against Johnson & Johnson over an alleged link between its baby powder products and ovarian cancer in adult women who used the product for long periods of time.

The suit's plaintiffs include a number of women and family members living in Ontario and Quebec, and the estate of a Montreal woman who died of ovarian cancer in March at age 66.

Two Toronto law firms are handling the class-action against the Canadian subsidiary of Johnson & Johnson, which also faces a wave of litigation in the United States.

The suits follow a jury decision in Missouri that awarded US$72 million to the family of a woman who died of ovarian cancer after using Johnson & Johnson feminine hygience products for years that contained its talcum powder.

Earlier this month, Johnson & Johnson was ordered by another U.S. jury to pay US$55 million in damages to a woman who claimed her ovarian cancer was caused by long term use of Johnson's baby powder.

The company has said it stands by the safety of its baby powder. Johnson & Johnson Canada didn't immediately reply to a request for a comment.

Among other requests, the Canadian suit is asking the Ontario Court of Justice to declare that the company was negligent and failed to warn of the health risks associated with the product. It says requests for monetary compensation will come later.